PRAME Recombinant Rabbit Monoclonal Antibody

PRAME (preferentially expressed antigen in melanoma) is a cancer/testis antigen not normally expressed in any tissues except testis, but is upregulated in tumors. PRAME is expressed in melanoma cells and is recognized by cytolytic T-cells. It is also upregulated in other diseases, such as synovial sarcoma, NSCLC, and breast cancer, where it is thought to contribute to tumorigenesis and metastasis. PRAME is also highly expressed in liquid tumors such as AML and can be predictive of clinical outcome in some circumstances.

Specifications

Catalog No.
BX50271
Clone No.
BP6248
Application
IHC-P
Subcellular location
Nucleus
Control
Melanoma
Recommended method
HIER
Volume
100μl/vial, 1ml/vial
Dilution
1:100-1:200
Immunogen
Recombinant protein fragment of human PRAME was used as an immunogen.

Reference

1. Qin, Y.Z. et al. (2017) Oncol Lett 13, 2823-2830.
2. Lura, K. et al. (2017) Hum Pathol 61, 130-139.

Support Documents

Order

  • E-mail : sales@biolynx.cn

Contact Us

Address
Hangzhou Bailing (Biolynx)  Biotechnology Co., Ltd. Room 1303 Bldg 5, #688 Bin’an Road Tianhe High-tech Park, Binjiang District Hangzhou, Zhejiang, China
310052
Phone & Fax
+86 571 88177680
+86 571 88177681
Web & Mail
Email:sales@biolynx.cn
www.biolynxtec.com

Follow Us

Scan QR Codes on Your Phone